Deep artificial intelligence is no longer the stuff of science fiction. It is embedded in the machinery of our lives, and nowhere is its impact more profound—or more fraught with questions—than in healthcare.
Agentic AI, a form of artificial intelligence capable of operating independently, making complex decisions, and executing tasks with minimal human intervention, is reshaping the field. Its promise is immense—a future where diagnoses are more precise, health systems hum with newfound efficiency, and treatments are tailored to each patient’s molecular makeup.
Yet, as this technology ascends, so too does a labyrinth of ethical, legal, and social dilemmas. The question is no longer whether AI will transform medicine—but at what cost, and who will bear it?
Sharpening Diagnostic Acumen
Medicine has always occupied that uneasy space between art and science. A seasoned physician, having spent decades in the trenches of clinical practice, might spot the faintest trace of a rare disease—an instinct sharpened through years of experience. But even the sharpest human judgment is fallible. Diagnostic inconsistency remains one of modern medicine’s most persistent flaws.
Unlike traditional machine learning models, which “merely” process vast amounts of data at superhuman speeds, this new breed of artificial intelligence doesn’t just analyze—it decides. It adapts. It refines its own methodologies in real time.
In gastroenterology, doctors are increasingly relying on AI-powered imaging systems to catch early-stage stomach cancers—cases that, left to human eyes alone, might slip through the cracks. These systems don’t simply assist; they learn. With every scan, they adjust, sharpening their own algorithms to improve detection rates. Meanwhile, in obstetrics, agentic AI is parsing fetal MRIs and ultrasound scans with an unprecedented level of precision, cutting through the diagnostic gray areas that have long confounded even the most experienced specialists.
What sets agentic AI apart is its ability to evolve. Unlike conventional AI, which adheres to static programming, these models rewrite their own playbooks. At Charles Darwin University, in collaboration with Australian Catholic University, researchers have developed an AI system capable of diagnosing pneumonia, COVID-19, and other lung diseases with a remarkable 96.57% accuracy. Using lung ultrasound videos, the model dissects each frame, pinpointing patterns that might elude even the most discerning human radiologist. But here’s the real breakthrough: by leveraging explainable AI techniques, it provides transparent rationales for each diagnosis, ensuring that doctors can trust and, more crucially, understand its reasoning.
Excerpt and image taken from the study:
“Information on four classes of diseases was collected from multiple medical experts and accumulated in Table 6. It perfectly aligns with our AI model’s findings, which shows our model’s competence in effectively classifying the disease into four classes: COVID-19, pneumonia, normal, and others.”
Across the Atlantic, the UK’s National Health Service (NHS) is undertaking one of the most ambitious AI trials to date: an £11 million initiative integrating AI into breast cancer screenings. Nearly 700,000 women are enrolled in the program, which pits agentic AI against the conventional mammogram review process. It examines past cases, adjusts its detection criteria in real-time, and even learns from radiologists’ corrections. The aim? A self-improving diagnostic system capable of catching malignancies earlier and with greater consistency than any human radiologist ever could.
Streamlining the System
Beyond diagnostics, AI is reshaping the very infrastructure of healthcare, particularly in administrative tasks that have long burdened both providers and patients. The contact center, often the first point of interaction for many patients, is being transformed by agentic AI.
AI systems capable of managing patient calls, scheduling appointments, and handling prescription refills—all without the need for human intervention—are already live and in action across some of the leading healthcare organizations in the US. AI-powered agents can guide patients through the process of booking physician visits, rescheduling appointments, and even providing proactive, automated reminders.
Top call drivers from over 10 million patient calls, as analyzed by Hyro. More than 85% of these drivers can be automated using agentic AI:
AI can integrate with electronic health records (EHRs) to streamline insurance verifications, pre-authorizations, and billing inquiries, alleviating the bureaucratic load on medical staff. This automation frees up healthcare workers to focus on patient care rather than low-touch administrative requests, a shift that has already yielded tangible benefits. Intermountain Health, for one example, has been able to leverage agentic AI to slash call abandonment rates by 85% and automate 44% of repetitive inbound calls.
The Personalized Prescription
Healthcare aspires to be personal. The ideal treatment is not one-size-fits-all, but tailored, down to the individual’s genes, lifestyle, and unique biological markers. AI is making this vision tangible.
Take the burgeoning field of AI-powered genomics. By analyzing a patient’s genetic data alongside lifestyle factors, AI can predict the efficacy of specific treatments, guiding physicians toward the most promising course of action. In chronic disease management, AI-integrated wearables are transforming patient monitoring. Devices that track vital signs in real-time can alert doctors to subtle changes—an irregular heartbeat, a dangerous spike in blood pressure—long before they manifest into full-blown medical crises.
Recent studies have underscored AI’s potential in this domain. Health facilities leveraging agentic AI have seen a marked reduction in hospital readmission rates. Predictive analytics, trained on millions of data points, can forecast which patients are at greatest risk of complications, enabling preemptive intervention.
The Ethical Minefield
Yet, for all its promise, agentic AI introduces dilemmas that medicine has never before encountered. The fundamental challenge: AI systems require vast troves of patient data to function effectively. This raises a critical question—who controls that data? Ensuring patient privacy in an age where personal health information is more valuable than ever is no small task.
Equally concerning is the issue of algorithmic bias. AI, for all its sophistication, is only as unbiased as the data on which it is trained. If that data skews toward particular demographics, the resulting algorithms can perpetuate disparities rather than erase them. Studies have already shown that AI diagnostic tools trained predominantly on datasets from white patients perform worse when analyzing images of Black and Latino patients. How do we correct for this imbalance?
There is also the issue of liability. If an AI system misdiagnoses a patient, who bears responsibility? The doctor who used it? The developer who programmed it? The hospital that deployed it? These are questions that medical ethics and legal systems have yet to answer definitively.
An Airtight Standard for Responsible AI
Hyro’s Triple C framework—Control, Compliance, and Clarity—offers a structured approach to ensuring that AI serves as a reliable asset rather than an unpredictable variable.
Control
The promise of agentic AI in healthcare hinges on accuracy, but without guardrails, AI can generate misleading or entirely fabricated responses—so-called hallucinations—that undermine trust and introduce risk.
Hyro’s framework ensures AI operates within clearly defined parameters, pulling responses only from pre-approved, authoritative sources. By maintaining full oversight of data inputs, healthcare teams can prevent AI from veering into speculation and ensure that every interaction aligns with institutional policies and clinical best practices.
Compliance
As HIPAA, GDPR, and other compliance frameworks evolve, AI systems must adapt in real time, ensuring airtight protections against breaches and misuse. A responsible AI framework doesn’t just check the compliance box; it anticipates change, keeping organizations ahead of shifting legal and ethical standards.
Clarity
Trust in AI depends on transparency. Traditional generative models function as opaque black boxes, offering little insight into how they reach conclusions. This lack of visibility makes it difficult—if not impossible—to correct errors, trace sources, or establish accountability.
Hyro’s approach prioritizes explainability, ensuring that every AI-generated response is auditable, traceable, and grounded in verifiable data. When healthcare professionals can see and understand the logic behind AI decisions, they can integrate automation with confidence rather than caution.
In an industry where trust is paramount, responsible AI isn’t just a goal—it’s the price of admission.
The Road Ahead
The challenge ahead is not just about innovation but governance. Policymakers, healthcare leaders, and AI developers must work in concert to build regulatory frameworks that prioritize transparency, fairness, and accountability. AI’s role in decision-making must be explainable, its biases identified and mitigated, and—most critically—it must complement, not supplant, human judgment.
The future of medicine may increasingly be shaped by algorithms, but its foundation remains human: compassion, equity, and trust.
Conversational AI insights,
directly to your inbox.
Ziv is Hyro’s Head of Content, a conversational AI expert, and a passionate storyteller devoted to delivering his audiences with insights that matter when they matter most. When he’s not obsessively consuming or creating content on digital health and AI, you can find him rocking out to Fleetwood Mac with his four-year-old son.
